The Rift Valley fever virus usually affects livestock, causing abortions and deaths in newborn animals, but it can also be passed to humans (zoonosis). An experimental vaccine is in development — a live attenuated strain of the virus, known as MP-12 — but this has not completed early clinical trials, partly because of concerns that it could still cause disease (virulence). Researchers from UTMB are developing an improved version that could make an impact against this growing disease. Coverage also appears in Science Daily, FierceVaccines.com, Galvmed, BioPortfolio, HighBeam Research, Biotech Mashup and WittySparks.
Original UTMB News Release